Marex Group Limited
NASDAQMarex Group heads into November earnings with analyst conviction unusually high for a stock that has already gained 75% this year. The most striking data point this week is fresh out of Barclays. On October 7, Benjamin Budish raised his price target from $86 to $92 while maintaining Overweight, the second time he has lifted the target in two months. Piper Sandler moved in the same…
MRX cost to borrow surges to 3.56% — up 512% over one week, a dramatic spike from near-zero rates as borrow demand intensifies despite abundant share availability.
Marex Group heads into November earnings with analyst conviction unusually high for a stock that has already gained 75% this year. The most striking data point this week is fresh out of Barclays. On October 7, Benjamin…
Marex Group Limited has done something notable this week: the stock rallied 20% to $71.88 while analysts scrambled to lift targets after the earnings print, creating a rare moment where the Street is chasing price…
Snapshot as of 14 Oct 2026
Marex Group Limited has slid 6.5% this week to $59.93, crossing the August 12 earnings line and coming out the other side with shorts covering and the analyst price target consensus sitting well above the current price…
Marex Group Limited enters its August 12 earnings print in an unusual position: the CEO has been selling stock while analysts are racing to lift their price targets higher. The insider activity is the standout this…
MRX enters the second half of July with a rare alignment: analysts raising targets aggressively, short sellers unwinding positions, and the borrow market as loose as it has been all year. The Street's conviction on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRX — free to start on ORTEX.
Sign up for free →Open MRX on ORTEX